The staff at Pharmaceutical Representative hit the bookstores looking for some of the most interesting sales, business and finance titles this season. Here's what we found.
The staff at Pharmaceutical Representative hit the bookstores looking for some of the most interesting sales, business and finance titles this season. Here's what we found.
•Â "Brain$ell: Harnessing the Selling Power of Your Whole Brain" by Tony Buzan and Richard Israel, $19.95 hard cover from McGraw-Hill. Want to know if your a left-brained or right-brained sales rep? Read the book.
•Â "Stop Selling, Start Partnering" by Larry Wilson with Hersch Wilson, $14.95 paperback from John Wiley and Sons Inc. Learn how to keep customers through long-lasting relationships.
•Â "Chicken Soup for the Soul at Work" by Jack Canfield and others, $12.95 paperback from Health Communications Inc. Stories from Alex Haley, Dave Thomas and others provide examples of courage and creativity on the job.
•Â "The Greatest Sales Stories Ever Told: From the World's Best Salespeople" by Robert L. Shook, $18.95 hard cover from McGraw-Hill. The book offers selling tips from experts in a broad range of industries.
•Â "How to Drive Your Competition Crazy" by Guy Kawasaki, $12.95 from Hyperion. A Forbes columnist gives tips for launching a new product or holding your own against a competitor with greater resources.
•Â "Talking from 9 to 5" by Deborah Tannen, Ph.D., $12.50 paperback from Avon Books, a division of Hearst Corp. The author of "You Just Don't Understand" looks at how men and women communicate in the workplace.
•Â "People, Performance and Pay: Dynamic Compensation for Changing Organizations" by Thomas P. Flannery and others from The Hay Group, $27.00 hard cover from The Free
Press. A book for managers that explains how companies can align their pay policy with their work culture. PR
What Every Pharma CEO Should Know About Unlocking the Potential of Scientific Data
December 11th 2024When integrated into pharmaceutical enterprises, scientific data has the potential to drive organizational growth and innovation. Mikael Hagstroem, CEO at leading laboratory informatics provider LabVantage Solutions, discusses how technology partners add significant value to pharmaceutical R&D, in addition to manufacturing quality.
Key Findings of the NIAGARA and HIMALAYA Trials
November 8th 2024In this episode of the Pharmaceutical Executive podcast, Shubh Goel, head of immuno-oncology, gastrointestinal tumors, US oncology business unit, AstraZeneca, discusses the findings of the NIAGARA trial in bladder cancer and the significance of the five-year overall survival data from the HIMALAYA trial, particularly the long-term efficacy of the STRIDE regimen for unresectable liver cancer.